ÂÜÀòÂÒÂ×

Clara C. serves as the Vice President and Head of Molecular Design at Bayer Pharmaceuticals, with a focus on leading Structural Biology and Computational Molecular Design since April 2013. Previously, Clara held roles including Director of Computational Molecular Design in Berlin and interim Head of Computational Life Science IT, concentrating on cross-functional initiatives. Early experience includes advancing drug discovery projects in oncology at Bayer through computer-aided methods and a track record of successful compound design supported by numerous research patents. Prior roles at Boehringer Ingelheim included R&D Scientist and Post-Doc in Computational Chemistry, focusing on various therapeutic areas. Clara's academic credentials comprise a Dr. sc. from ETH Zürich, along with multiple degrees in Chemistry from ETH Zürich and other institutions.